Wanandi SI, Limanto A, Yunita E, Syahrani RA, et al. Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells. PLoS One 2021;16:e0247694.
PMID: 33621270